Differential regulation of steroid nuclear receptor coregulator expression between normal and neoplastic prostate epithelial cells

Hannelore V. Heemers, Lucy J. Schmidt, Emily Kidd, Kristin A. Raclaw, Kevin M. Regan, Donald J. Tindall

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

BACKGROUND. Deregulated androgen receptor (AR) action is critical for prostate cancer (PCa) progression. Aberrant expression of AR-associated coregulators contributes to AR activity in PCa. The mechanisms underlying coregulator expression in PCa are under intense investigation as they may lead to alternative means of targeting AR activity in PCa cells. We have recently shown that over 30% of coregulator expression in the PCa cell line LNCaP is subject to androgen regulation. METHODS. Using multiple PCa cell lines as well as xenograft models, non-malignant prostate epithelial cell lines and androgen-responsive tissues derived from a male Wistar rat model system, we explored the effect of androgen stimulation and androgen deprivation on the expression of the core coactivators SRC1, SRC2, SRC3, CBP, and p300. RESULTS. Androgen stimulation of model systems representing PCa led to a decrease in the expression of SRC1, SRC2, SRC3, CBP, and p300, whereas androgen deprivation induced the expression of these coactivators. In contrast, expression of these coregulators remained largely unaffected following changes in the androgenic milieu in AR-positive models representing non-malignant prostate cells and tissues. CONCLUSIONS. Our data indicate differences in the regulation of coregulator expression between neoplastic and normal prostate cells. These findings emphasize the important potential of targeting the mechanisms regulating coregulator expression for therapeutic intervention in PCa.

Original languageEnglish (US)
Pages (from-to)959-970
Number of pages12
JournalProstate
Volume70
Issue number9
DOIs
StatePublished - Jun 15 2010

Fingerprint

Steroid Receptors
Cytoplasmic and Nuclear Receptors
Prostate
Prostatic Neoplasms
Epithelial Cells
Androgens
Androgen Receptors
Cell Line
Heterografts
Wistar Rats

Keywords

  • Androgen receptor
  • Coactivator
  • Cofactor
  • Coregulator
  • Corepressor
  • Prostate cancer

ASJC Scopus subject areas

  • Urology
  • Oncology

Cite this

Heemers, H. V., Schmidt, L. J., Kidd, E., Raclaw, K. A., Regan, K. M., & Tindall, D. J. (2010). Differential regulation of steroid nuclear receptor coregulator expression between normal and neoplastic prostate epithelial cells. Prostate, 70(9), 959-970. https://doi.org/10.1002/pros.21130

Differential regulation of steroid nuclear receptor coregulator expression between normal and neoplastic prostate epithelial cells. / Heemers, Hannelore V.; Schmidt, Lucy J.; Kidd, Emily; Raclaw, Kristin A.; Regan, Kevin M.; Tindall, Donald J.

In: Prostate, Vol. 70, No. 9, 15.06.2010, p. 959-970.

Research output: Contribution to journalArticle

Heemers, Hannelore V. ; Schmidt, Lucy J. ; Kidd, Emily ; Raclaw, Kristin A. ; Regan, Kevin M. ; Tindall, Donald J. / Differential regulation of steroid nuclear receptor coregulator expression between normal and neoplastic prostate epithelial cells. In: Prostate. 2010 ; Vol. 70, No. 9. pp. 959-970.
@article{44a9a532f7844c0194582d0e2dd44711,
title = "Differential regulation of steroid nuclear receptor coregulator expression between normal and neoplastic prostate epithelial cells",
abstract = "BACKGROUND. Deregulated androgen receptor (AR) action is critical for prostate cancer (PCa) progression. Aberrant expression of AR-associated coregulators contributes to AR activity in PCa. The mechanisms underlying coregulator expression in PCa are under intense investigation as they may lead to alternative means of targeting AR activity in PCa cells. We have recently shown that over 30{\%} of coregulator expression in the PCa cell line LNCaP is subject to androgen regulation. METHODS. Using multiple PCa cell lines as well as xenograft models, non-malignant prostate epithelial cell lines and androgen-responsive tissues derived from a male Wistar rat model system, we explored the effect of androgen stimulation and androgen deprivation on the expression of the core coactivators SRC1, SRC2, SRC3, CBP, and p300. RESULTS. Androgen stimulation of model systems representing PCa led to a decrease in the expression of SRC1, SRC2, SRC3, CBP, and p300, whereas androgen deprivation induced the expression of these coactivators. In contrast, expression of these coregulators remained largely unaffected following changes in the androgenic milieu in AR-positive models representing non-malignant prostate cells and tissues. CONCLUSIONS. Our data indicate differences in the regulation of coregulator expression between neoplastic and normal prostate cells. These findings emphasize the important potential of targeting the mechanisms regulating coregulator expression for therapeutic intervention in PCa.",
keywords = "Androgen receptor, Coactivator, Cofactor, Coregulator, Corepressor, Prostate cancer",
author = "Heemers, {Hannelore V.} and Schmidt, {Lucy J.} and Emily Kidd and Raclaw, {Kristin A.} and Regan, {Kevin M.} and Tindall, {Donald J.}",
year = "2010",
month = "6",
day = "15",
doi = "10.1002/pros.21130",
language = "English (US)",
volume = "70",
pages = "959--970",
journal = "Prostate",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "9",

}

TY - JOUR

T1 - Differential regulation of steroid nuclear receptor coregulator expression between normal and neoplastic prostate epithelial cells

AU - Heemers, Hannelore V.

AU - Schmidt, Lucy J.

AU - Kidd, Emily

AU - Raclaw, Kristin A.

AU - Regan, Kevin M.

AU - Tindall, Donald J.

PY - 2010/6/15

Y1 - 2010/6/15

N2 - BACKGROUND. Deregulated androgen receptor (AR) action is critical for prostate cancer (PCa) progression. Aberrant expression of AR-associated coregulators contributes to AR activity in PCa. The mechanisms underlying coregulator expression in PCa are under intense investigation as they may lead to alternative means of targeting AR activity in PCa cells. We have recently shown that over 30% of coregulator expression in the PCa cell line LNCaP is subject to androgen regulation. METHODS. Using multiple PCa cell lines as well as xenograft models, non-malignant prostate epithelial cell lines and androgen-responsive tissues derived from a male Wistar rat model system, we explored the effect of androgen stimulation and androgen deprivation on the expression of the core coactivators SRC1, SRC2, SRC3, CBP, and p300. RESULTS. Androgen stimulation of model systems representing PCa led to a decrease in the expression of SRC1, SRC2, SRC3, CBP, and p300, whereas androgen deprivation induced the expression of these coactivators. In contrast, expression of these coregulators remained largely unaffected following changes in the androgenic milieu in AR-positive models representing non-malignant prostate cells and tissues. CONCLUSIONS. Our data indicate differences in the regulation of coregulator expression between neoplastic and normal prostate cells. These findings emphasize the important potential of targeting the mechanisms regulating coregulator expression for therapeutic intervention in PCa.

AB - BACKGROUND. Deregulated androgen receptor (AR) action is critical for prostate cancer (PCa) progression. Aberrant expression of AR-associated coregulators contributes to AR activity in PCa. The mechanisms underlying coregulator expression in PCa are under intense investigation as they may lead to alternative means of targeting AR activity in PCa cells. We have recently shown that over 30% of coregulator expression in the PCa cell line LNCaP is subject to androgen regulation. METHODS. Using multiple PCa cell lines as well as xenograft models, non-malignant prostate epithelial cell lines and androgen-responsive tissues derived from a male Wistar rat model system, we explored the effect of androgen stimulation and androgen deprivation on the expression of the core coactivators SRC1, SRC2, SRC3, CBP, and p300. RESULTS. Androgen stimulation of model systems representing PCa led to a decrease in the expression of SRC1, SRC2, SRC3, CBP, and p300, whereas androgen deprivation induced the expression of these coactivators. In contrast, expression of these coregulators remained largely unaffected following changes in the androgenic milieu in AR-positive models representing non-malignant prostate cells and tissues. CONCLUSIONS. Our data indicate differences in the regulation of coregulator expression between neoplastic and normal prostate cells. These findings emphasize the important potential of targeting the mechanisms regulating coregulator expression for therapeutic intervention in PCa.

KW - Androgen receptor

KW - Coactivator

KW - Cofactor

KW - Coregulator

KW - Corepressor

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=77952912790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952912790&partnerID=8YFLogxK

U2 - 10.1002/pros.21130

DO - 10.1002/pros.21130

M3 - Article

C2 - 20166126

AN - SCOPUS:77952912790

VL - 70

SP - 959

EP - 970

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 9

ER -